Literature DB >> 31077634

Psoriasis and pregnancy outcomes in biological therapies: a real-life, multi-centre experience.

G Odorici1, V Di Lernia2, F Bardazzi3, M Magnano3, S Di Nuzzo4, C Cortelazzi4, C Lasagni1, L Bigi1, M Corazza5, G Pellacani1, A Conti1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31077634     DOI： 10.1111/jdv.15671

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  3 in total

1.  Considerations on inhibition of IL-23 in psoriatic women of childbearing potential.

Authors:  Roberto Russo; Giulia Gasparini; Emanuele Cozzani; Martina Burlando; Aurora Parodi
Journal:  Dermatol Ther       Date:  2021-03-17       Impact factor: 2.851

2.  Intrauterine Exposure to Biologics in Inflammatory Autoimmune Diseases: A Systematic Review.

Authors:  N Ghalandari; R J E M Dolhain; J M W Hazes; E P van Puijenbroek; M Kapur; H J M J Crijns
Journal:  Drugs       Date:  2020-11       Impact factor: 9.546

Review 3.  Impact of Psoriasis and Hidradenitis Suppurativa in Pregnancy, a Systematic Review.

Authors:  Maria-Angeles Ferrer-Alcala; Manuel Sánchez-Díaz; Salvador Arias-Santiago; Alejandro Molina-Leyva
Journal:  J Clin Med       Date:  2021-12-15       Impact factor: 4.241
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.